|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000033538 |
|
最近更新日期: Date of Last Refreshed on: |
2020-06-04 18:57:28 |
|
注册时间: Date of Registration: |
1990-01-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
待编辑(三)儿童结直肠息肉管理项目 |
|
Public title: |
Pediatric colorectal polyp care |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
儿童结直肠息肉管理项目 |
|
Scientific title: |
Pediatric colorectal polyp care |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
方莹 |
研究负责人: |
方莹 |
|
Applicant: |
Ying Fang |
Study leader: |
Ying Fang |
|
申请注册联系人电话: Applicant telephone: |
18602907819 |
研究负责人电话:
Study leader's |
18602907819 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
970910576@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
970910576@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
陕西省西安市西举院巷69号 |
研究负责人通讯地址: |
陕西省西安市西举院巷69号 |
|
Applicant address: |
NO.69 xijuyuan lane, xi 'an city, shaanxi province, China |
Study leader's address: |
NO.69 xijuyuan lane, xi 'an city, shaanxi province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
710003 |
研究负责人邮政编码: Study leader's postcode: |
|
|
申请人所在单位: |
西安市儿童医院 |
||
|
Applicant's institution: |
NO.69 xijuyuan lane, xi 'an city, shaanxi province, China |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2020-001-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
西安市儿童医院药物临床试验伦理委员会 |
||
|
Name of the ethic committee: |
Ethics committee for clinical drug trials of xi 'an children's hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-05-27 00:00:00 | ||
|
伦理委员会联系人: |
苟凯华 |
||
|
Contact Name of the ethic committee: |
Kaihua Gou |
||
|
伦理委员会联系地址: |
陕西省西安市西举院巷69号 |
||
|
Contact Address of the ethic committee: |
NO.69 xijuyuan lane, xi 'an city, shaanxi province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
西安市儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xi'an Children's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
陕西省西安市西举院巷69号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
NO.69 xijuyuan lane, xi 'an city, shaanxi province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
基金会及自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Foundations and self-financing |
||||||||||||||||||||||
|
研究疾病: |
儿童结直肠息肉 |
||||||||||||||||||||||
|
Target disease: |
Pediatric colorectal polyps |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
了解中国儿童中结直肠息肉的患病情况、临床及内镜特征,探究发病相关危险因素并提出预防方法;初步建立基于机器学习的内镜下息肉性质智能识别系统;完善优化儿童结肠镜检查围手术期管理及肠道准备流程及内镜下结直肠息肉切除术的标准化诊治流程。探索遗传性结直肠息肉病的风险因素及发病机制。 |
||||||||||||||||||||||
|
Objectives of Study: |
To understand the prevalence, clinical and endoscopic features of colorectal polyps in Chinese children, to explore the risk factors associated with the disease and propose preventive measures. To establish initially an intelligent recognition system for endoscopic polyps based on machine learning. To improve and optimize the perioperative management and intestinal preparation of children undergoing colonoscopy and the standardized diagnosis and treatment of endoscopic colorectal polyps. To explore the risk factors and pathogenesis of hereditary colorectal polyps. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄0~18周岁接受结肠镜检查的患儿; |
||||||||||||||||||||||
|
Inclusion criteria |
(1) pediatrics aged between 0 and 18 who underwent colonoscopy; |
||||||||||||||||||||||
|
排除标准: |
(1)患有心肺疾病或其他严重基础疾病; |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Having heart and lung disease or other serious underlying disease; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2019-08-01 00:00:00至 To 2022-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-08-10 00:00:00 至 To 2022-04-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
如果患者符合本研究的入组条件,在签署书面知情同意书并且研究医师认为该患者具备研究资格后,将采用随机数表法对患者进行随机分配,具体为:从随机数表法中任意一个随机数字开始,向右连续选取数字,纳入研究的患儿按照就诊顺序依次对应连续的随机数字,随机数字按照大小分组后入各组别。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
If the patients are eligible for inclusion in the studys, with a written informed consent and the study doctor thinks the patient conform to the qualified research, Patients were randomly assigned using the random number table methods.As follows: a random number from the random indicator method, continuous sele |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2023年2月份,网络平台 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
February 2023, network platform |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集和管理基于互联网,质控组定期审查 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection and management based on the Internet, quality control group regularly review |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |